Campbell, John D. M.

Safety profile of autologous macrophage therapy for liver cirrhosis

Moroni, F., Dwyer, B. J., Graham, C., Pass, C., Bailey, L., Ritchie, L., Mitchell, D., Glover, A., Laurie, A., Doig, S., et al. (2019) · Nature Medicine

Liver physiology and pathologyLiver Disease and Transplantation

Cited by 202

Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial

Newsome, P. N., Fox, R., King, A. L., Barton, D., Than, N.-N., Moore, J., Corbett, C., Townsend, S., Thomas, J., Guo, K., et al. (2018) · The Lancet Gastroenterology & Hepatology

Liver Disease and TransplantationMesenchymal stem cell research

Cited by 162

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine

Liver Disease and TransplantationLiver physiology and pathology

Cited by 66

Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization

Forbes, S., Bond, A. R., Thirlwell, K. L., Burgoyne, P., Samuel, K., Noble, J., Borthwick, G., Colligan, D., McGowan, N. W. A., Lewis, P. S., et al. (2020) · Science Translational Medicine

Pancreatic function and diabetesMesenchymal stem cell research

Cited by 54

LBP-007 Beneficial effects of autologous macrophage therapy on clinical outcomes in patients with compensated cirrhosis: extended follow-up data from a randomized controlled phase 2 trial

Brennan, P., Macpherson, I., Troland, D., Kilpatrick, A. M., Manship, T., McGowan, N., Campbell, J., Fraser, A., Pass, C., Moroni, F., et al. (2024) · Journal of Hepatology

Liver Disease and TransplantationLiver physiology and pathology

Cited by 3